Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders

Pflugers Archiv European Journal of Physiology

Volumn 444, Issue 3, 2002, Pages 317-326

  Tenenhouse, Harriet S ^a,b   Sabbagh, Yves ^a,b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

FGF 23; Hypophosphatemic rickets; Npt2; PHEX; Phosphate transport

Indexed keywords

COTRANSPORTER; PARATHYROID HORMONE; PHOSPHATE; SODIUM; SODIUM DIHYDROGEN PHOSPHATE;

AUTOSOMAL DOMINANT INHERITANCE; BRUSH BORDER; CARCINOGENICITY; FGF23 GENE; GENE; GENE DISRUPTION; GENE INSERTION; HOMEOSTASIS; HUMAN; HYPOPHOSPHATEMIA; KIDNEY; KIDNEY PROXIMAL TUBULE; MAMMAL; NONHUMAN; NPT2 GENE; PATHOGENESIS; PATHOPHYSIOLOGY; PHEX GENE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RICKETS; SKELETON MALFORMATION; VITAMIN D RESISTANT RICKETS; WASTING SYNDROME;

ANIMALS; HUMANS; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIA, FAMILIAL; KIDNEY DISEASES; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; SYMPORTERS;

EID: 0036448310     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00424-002-0839-4     Document Type: Review

References (90)

1. ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348
2. Agus ZS (1983) Oncogenic hypophosphatemic osteomalacia. Kidney Int 24:113-123
3. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria and skeletal abnormalities. Proc Natl Acad Sci USA 95:5372-5377
4. +-phosphate cotransporter mRNA and protein: Effect of the Gy mutation and low phosphate diet. Pflugers Arch 431:936-941
5. Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer C, Tenenhouse HS (1997) Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99:1200-1209
6. Berndt TJ, Knox FG (1992) Renal regulation of phosphate excretion. In: Seldin DW, Giebisch G (eds) The Kidney, Physiology and Pathophysiology. Raven, New York, pp 2511-2532
7. Biber J (2001) Emerging roles of transporter-PDZ complexes in renal proximal tubular reabsorption. Pflugers Arch 443:3-5
8. Biber J, Custer M, Werner A, Kaissling B, Murer H (1993) Localization of NaPi-1, a Na/Pi cotransporter, in rabbit kidney proximal tubules. II. Localization by immunohistochemistry. Pflugers Arch 424:210-215
9. Boileau G, Tenenhouse HS, DesGroseillers L, Crine P (2001) Characterization of PHEX endopeptidase catalytic activity: Identification of parathyroid-hormone-related peptide 107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors. Biochem J 355:707-713
10. Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, Schiavi SC (2001) Fgf-23 inhibits renal tubular phosphate transport and is a phex substrate. Biochem Biophys Res Commun 284:977-981
11. Broer S, Schuster A, Wagner CA, Broer A, Forster I, Biber J, Murer H, Werner A, Lang F, Busch AE (1998) Chloride conductance and Pi transport are separate functions induced by the expression of NaPi-1 in Xenopus oocytes. J Membr Biol 164:71-77
12. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R (1994) Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. New Engl J Med 330:1645-1649
13. Custer M, Lötscher M, Biber J, Murer H, Kaissling B (1994) Expression of Na-Pi cotransport in rat kidney: Localization by RT-PCR and immunohistochemistry. Am J Physiol 266:F767-F774
14. Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C, Ecarot B (1996) cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36:22-28
15. 3 down-regulates expression of Phex, a marker of the mature osteoblast. Endocrinology 140:1192-1199
16. Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L (1992) Defective bone formation by Hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect. J Bone Miner Res 7:215-220
17. Econs MJ, Drezner MK (1994) Tumor-induced osteomalacia - Unveiling a new hormone. N Engl J Med 330:1679-1681
18. Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate wasting disorder. J Clin Endocrinol Metab 82:674-681
19. Econs MJ, McEnery PT, Lennon F, Speer MC (1997) Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 100:2653-2657
20. Eicher EM, Southard JL, Scriver CR, Glorieux FH (1976) Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73:4667-4671
21. Emoto N, Yanagisawa M (1995) Endothelin-converting enzyme-2 is a membrane bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262-15268
22. Francis F, Strom TM, Hennig S, Boddrich A, Lorenz B, Brandau O, Mohnike KL, Cagnoli M, Steffens C, Klages S, Borzym K, Pohl T, Oudet C, Econs MJ, Rowe PSN, Reinhardt R, Meitinger T, Lehrach H (1997) Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res 7:573-585
23. Gazit D, Tieder M, Liberman UA, Passi-Even L, Bab IA (1991) Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: A correlative clinical-histomorphometric study. J Clin Endocrinol Metab 72:229-235
24. Grabowski GA, Leslie N, Wenstrup R (1998) Enzyme therapy for Gaucher disease: The first 5 years. Blood Rev 12:115-133
25. Guo R, Liu S, Spurney RF, Quarles LD (2001) Analysis of recombinant Phex: An endopeptidase in search of a substrate. Am J Physiol 281:E837-E847
26. Guo R, Quarles D (1997) Cloning and sequencing of human PEX from a bone cDNA library: Evidence for its developmental stage-specific regulation in osteoblasts. J Bone Miner Res 12:1009-1017
27. -/- mice. Bone 29:467-476
28. Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J (1998) Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 95:14564-14569
29. Hoag HM, Martel J, Gauthier C, Tenenhouse HS (1999) Effects of Npt2 gene ablation and low-phosphate diet on renal Na/phosphate cotransport and cotransporter gene expression. J Clin Invest 104:679-686
30. HYP Consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136
31. Iorio RJ, Bell WA, Meyer MH, Meyer RA Jr (1979) Radiographic evidence of craniofacial and dental abnormalities in the X-linked hypophosphatemic mouse. Ann Dent 38:31-37
32. Jones AO, Tzenova J, Frappier D, Crumley M, Roslin NM, Kos CH, Tieder M, Langman CB, Proesmans W, Carpenter TO, Rice A, Anderson D, Morgan K, Fujiwara TM, Tenenhouse HS (2001) Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na/Pi cotransporter NPT2 gene. J Am Soc Nephrol 12:507-514
33. Jonsson KB, Mannstadt M, Miyauchi A, Yang IM, Stein G, Ljunggren O, Juppner H (2001) Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells. J Endocrinol 169:613-620
34. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD (1994) Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-phosphate symporters. Proc Natl Acad Sci USA 91:7071-7075
35. Kos CH, Tihy F, Econs MJ, Murer H, Lemieux N, Tenenhouse HS (1994) Localization of a renal sodium phosphate cotransporter gene to human chromosome 5q35. Genomics 19:176-177
36. +-phosphate cotransporter genes, NPT1 and NPT2, in human and rabbit. Cytogenet Cell Genet 75:22-24
37. Kumar R (2000) Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27:333-338
38. Lajeunesse D, Meyer RA Jr, Hamal L (1996) Direct evidence of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse: Involvement of an osteoblast-derived factor. Kidney Int 50:1531-1538
39. Lemay G, Waksman G, Roques BP, Crine P, Boileau G (1990) Fusion of a cleavable signal peptide to the ectodomain of neutral endopeptidase (EC 3.4.24.11) results in the secretion of an active enzyme in COS-1 cells. J Biol Chem 264:15620-15623
40. Levi M, Kempson SA, Lotscher M, Biber J, Murer H (1996) Molecular regulation of renal phosphate transport. J Membr Biol 154:1-9
41. Levi M, Lotscher M, Sorribas V, Custer M, Arar M, Kaissling B, Murer H, Biber J (1994) Cellular mechanisms of acute and chronic adaptation of rat renal phosphate transporter to alterations in dietary phosphate. Am J Physiol 267:F900-F908
42. Liu S, Guo R, Quarles LD (2001) Cloning and characterization of the proximal murine Phex promoter. Endocrinology 142:3987-3995
43. Liu S, Guo R, Tu Q, Quarles LD (2002) Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem 277:3686-3697
44. Lyon MF, Scriver CR, Baker LRI, Tenenhouse HS, Kronick J, Mandla S (1986) The Gy mutation: Another cause of X-linked hypophosphatemia in mouse. Proc Natl Acad Sci USA 83:4899-4903
45. Meyer RA Jr, Meyer MH, Gray RW (1989) Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res 4:493-500
46. Meyer RA Jr, Tenenhouse HS, Meyer MH, Klugerman AH (1989) The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy. J Bone Miner Res 4:523-532
47. Miao D, Bai X, Panda D, McKee M, Karaplis A, Goltzman D (2001) Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 142:926-939
48. Murer H, Biber J (1994) Renal sodium-phosphate cotransport. Curr Opin Nephrol Hypertens 3:504-510
49. Murer H, Biber J (1997) A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation. Pflugers Arch 433:379-389
50. Murer H, Forster I, Hilfiker H, Pfister M, Kaissling B, Lotscher M, Biber J (1998) Cellular/molecular control of renal Na/Pi-cotransport. Kidney Int Suppl 65:S2-S10
51. Murer H, Hernando N, Forster I, Biber J (2000) Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiol Rev 80:1373-1409
52. Murer H, Hernando N, Forster I, Biber J (2001) Molecular aspects in the regulation of renal inorganic phosphate reabsorption: The type IIa sodium/inorganic phosphate co-transporter as the key player. Curr Opin Nephrol Hypertens 10:555-561
53. Murer H, Werner A, Reshkin S, Wuarin R, Biber J (1991) Cellular mechanisms in proximal tubular reabsorption of inorganic phosphate. Am J Physiol 260:C885-C899
54. Nelson AE, Hogan JJ, Holm IA, Robinson BG, Mason RS (2001) Phosphate wasting in oncogenic osteomalacia: Phex is normal and the tumor-derived factor has unique properties. Bone 28:430-439
55. Nesbitt T, Coffman TM, Griffiths R, Drezner MK (1992) Cross-transplantation of kidneys in normal and Hyp mice: Evidence that the Hyp phenotype is unrelated to an intrinsic renal defect. J Clin Invest 89:1453-1459
56. Pfister MF, Hilfiker H, Forgo J, Lederer E, Biber J, Murer H (1998) Cellular mechanisms involved in the acute adaptation of OK cell Na/Pi-cotransport to high- or low-Pi medium. Pflugers Arch 435:713-719
57. Pfister MK, Ruf I, Stange G, Ziegler U, Lederer E, Biber J (1998) Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc Natl Acad Sci USA 95:1909-1914
58. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF (1996) Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76:127-173
59. Rasmussen H, Tenenhouse HS (1995) Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Basis of Inherited Disease. McGraw Hill, New York, pp 3717-3745
60. Roques BP, Noble F, Daugé V, Fournié-Zaluski M-C, Beaumont A (1993) Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87-146
61. Rowe PSN, Ong ACM, Cockerill FJ, Goulding JN, Hewison M (1996) Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia. Bone 18:159-169
62. Ruchon AF, Marcinkiewicz M, Siegfried G, Tenenhouse HS, DesGroseillers L, Crine P, Boileau G (1998) Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem 46:459-468
63. Ruchon AF, Tenenhouse HS, Marcinkiewicz M, Siegfried G, Aubin JE, DesGroseillers L, Crine P, Boileau G (2000) Developmental expression and tissue distribution of Phex protein: Effect of the Hyp mutation and relationship to bone markers. J Bone Mineral Res 15:1440-1450
64. Sabbagh Y, Boileau G, DesGroseillers L, Tenenhouse HS (2001) Disease-causing missense mutation in the PHEX gene interfere with membrane targeting of the recombinant protein. Hum Mol Genet 10:1539-1546
65. Sabbagh Y, Jones AO, Tenenhouse HS (2000) PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia. Hum Mutat 16:1-6
66. Sabbagh Y, Londowski JM, Mathiesen D, Gauthier C, Boileau G, Tenenhouse HS, Poeschla EM, Kumar R (2000) Stable transfection of PHEX in hypophosphatemic (Hyp) osteoblasts using a viral vector partially corrects the mutant cell phenotype. Implications for gene therapy [abstract]. J Am Soc Nephrol 11:413A
67. Shih NR, Jo OD, Yanagawa N (2002) Effects of PHEX anti-sense in human osteoblast cells. J Am Soc Nephrol 13:394-399
68. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505
69. Soumounou Y, Gauthier C, Tenenhouse HS (2001) Murine and human type I Na-phosphate cotransporter genes: Structure and promoter activity. Am J Physiol 281:F1082-F1091
70. Strom TM, Francis F, Lorenz B, Boeddrich A, Econs M, Lehrach H, Meitinger T (1997)Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6:165-171
71. Tenenhouse HS (1997) Cellular and molecular mechanisms of renal phosphate transport. J Bone Miner Res 12:159-164
72. Tenenhouse HS (1999) Recent advances in epithelial sodium-coupled phosphate transport. Curr Opin Nephrol Hypertens 8:407-414
73. Tenenhouse HS (1999) X-linked hypophosphatemia: A homologous disorder in humans and mice. Nephrol Dial Transplant 14:333-341
74. +-phosphate cotransporter gene expression in X-linked Hyp and Gy mice. Kidney Int 49:1027-1032
75. Tenenhouse HS, Econs MJ (2001) Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Basis of Inherited Disease. McGraw Hill, New York, pp 5039-5067
76. Tenenhouse HS, Klugerman AH, Neal JL (1989) Effect of phosphonoformic acid, dietary phosphate and the Hyp mutation on kinetically distinct phosphate transport processes in mouse kidney. Biochim Biophys Acta 984:207-213
77. Tenenhouse HS, Martel J, Gauthier C, Zhang MYH, Portale AA (2001) Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1α-hydroxylase by phosphate. Endocrinology 142:1124-1129
78. Tenenhouse HS, Meyer RA Jr, Mandla S, Meyer MH, Gray RW (1992) Renal phosphate transport and vitamin D metabolism in X-linked hypophosphatemic Gy mice: Responses to phosphate deprivation. Endocrinology 131:51-56
79. +-phosphate cotransporter genes in murine kidney. Am J Physiol 44:F527-F534
80. +-phosphate cotransport in murine X-linked hypophosphatemic rickets: Molecular characterization. J Clin Invest 93:671-676
81. Thompson DL, Sabbagh Y, Tenenhouse HS, Roche PC, Drezner MK, Salisbury JL, Grande JP, Poeschla EM, Kumar R (2002) Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res 17:311-320
82. Tieder M, Modai D, Samuel R, Arie R, Halabe A, Bab I, Gabizon D, Lieberman UA (1985) Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312:611-617
83. Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh Z, Cohen N, Edelstein S, Lieberman UA (1987) "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. N Engl J Med 316:125-129
84. Turner AJ, Tanzawa K (1997) Mammalian membrane metallopeptidases: NEP, ECE, KELL and PEX. FASEB J 11:355-364
85. White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079-2086
86. White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497-500
87. Wilkins GE, Granlesse S, Hegele RG, Holden J, Anderson DW, Bondy GP (1995) Oncogenic osteomalacia - Evidence for a humoral phosphaturic factor. J Clin Endocrin Metab 80:1628-1634
88. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485
89. Zhao N, Tenenhouse HS (2000) Npt2 gene disruption confers resistance to the inhibitory action of PTH on renal Na-phosphate cotransport. Endocrinology 141:2159-2165
90. Zoidis E, Gosteli-Peter M, Ghirlanda-Keller C, Meinel L, Zapf J, Schmid C (2002) IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats. Eur J Endocrinol 146:97-105